159 related articles for article (PubMed ID: 11122108)
1. Interferon alpha in combination with GM-CSF induces the differentiation of leukaemic antigen-presenting cells that have the capacity to stimulate a specific anti-leukaemic cytotoxic T-cell response from patients with chronic myeloid leukaemia.
Chen X; Regn S; Raffegerst S; Kolb HJ; Roskrow M
Br J Haematol; 2000 Nov; 111(2):596-607. PubMed ID: 11122108
[TBL] [Abstract][Full Text] [Related]
2. Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-alpha.
Wang C; Al-Omar HM; Radvanyi L; Banerjee A; Bouman D; Squire J; Messner HA
Exp Hematol; 1999 Jul; 27(7):1176-84. PubMed ID: 10390193
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the Philadelphia translocation and can induce a CML-specific primary cytotoxic T-cell response.
Eibl B; Ebner S; Duba C; Böck G; Romani N; Erdel M; Gächter A; Niederwieser D; Schuler G
Genes Chromosomes Cancer; 1997 Nov; 20(3):215-23. PubMed ID: 9365828
[TBL] [Abstract][Full Text] [Related]
4. Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia.
Choudhury A; Gajewski JL; Liang JC; Popat U; Claxton DF; Kliche KO; Andreeff M; Champlin RE
Blood; 1997 Feb; 89(4):1133-42. PubMed ID: 9028934
[TBL] [Abstract][Full Text] [Related]
5. b3a2 BCR-ABL fusion peptides as targets for cytotoxic T cells in chronic myeloid leukaemia.
Norbury LC; Clark RE; Christmas SE
Br J Haematol; 2000 Jun; 109(3):616-21. PubMed ID: 10886212
[TBL] [Abstract][Full Text] [Related]
6. GM-CSF can improve the cytogenetic response obtained with interferon-alpha therapy in patients with chronic myelogenous leukemia.
Cortes J; Kantarjian H; O'Brien S; Kurzrock R; Keating M; Talpaz M
Leukemia; 1998 Jun; 12(6):860-4. PubMed ID: 9639411
[TBL] [Abstract][Full Text] [Related]
7. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
[TBL] [Abstract][Full Text] [Related]
8. Cytokines required for induction of histocompatibility leukocyte antigen-class I-restricted and tumor-specific cytotoxic T lymphocytes by a SART1-derived peptide.
Matsunaga K; Nakao M; Masuoka K; Inoue Y; Gouhara R; Imaizumi T; Nishizaka S; Itoh K
Jpn J Cancer Res; 1999 Sep; 90(9):1007-15. PubMed ID: 10551332
[TBL] [Abstract][Full Text] [Related]
9. Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells.
Paquette RL; Hsu NC; Kiertscher SM; Park AN; Tran L; Roth MD; Glaspy JA
J Leukoc Biol; 1998 Sep; 64(3):358-67. PubMed ID: 9738663
[TBL] [Abstract][Full Text] [Related]
10. In vitro cytokine-primed leukaemia cells induce in vivo T cell responsiveness in chronic myeloid leukaemia.
Lim SH; Coleman S; Bailey-Wood R
Bone Marrow Transplant; 1998 Dec; 22(12):1185-90. PubMed ID: 9894722
[TBL] [Abstract][Full Text] [Related]
11. Rapid generation of antigen-presenting cells from leukaemic blasts in acute myeloid leukaemia.
Westers TM; Stam AG; Scheper RJ; Regelink JC; Nieuwint AW; Schuurhuis GJ; van de Loosdrecht AA; Ossenkoppele GJ
Cancer Immunol Immunother; 2003 Jan; 52(1):17-27. PubMed ID: 12536236
[TBL] [Abstract][Full Text] [Related]
12. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte macrophage colony-stimulating factor and interleukin 4 enhance the number and antigen-presenting activity of circulating CD14+ and CD83+ cells in cancer patients.
Roth MD; Gitlitz BJ; Kiertscher SM; Park AN; Mendenhall M; Moldawer N; Figlin RA
Cancer Res; 2000 Apr; 60(7):1934-41. PubMed ID: 10766183
[TBL] [Abstract][Full Text] [Related]
14. Production of granulocyte-macrophage colony-stimulating factor by T cells is regulated by B7 and IL-1 beta.
Kruger M; Van Gool S; Peng XH; Coorevits L; Casteels-Van Daele M; Ceuppens JL
Immunology; 1996 May; 88(1):49-54. PubMed ID: 8707349
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic and functional characterization of the host immune compartment of chronic myeloid leukaemia patients in complete haematological remission.
Guarini A; Breccia M; Montefusco E; Petti MC; Zepparoni A; Vitale A; Foa R
Br J Haematol; 2001 Apr; 113(1):136-42. PubMed ID: 11328293
[TBL] [Abstract][Full Text] [Related]
16. Recognition of chronic myelogenous leukaemia cells by autologous T lymphocytes primed in vitro against the patient's dendritic cells.
Müller L; Provenzani C; Faul C; Pawelec G
Br J Haematol; 2001 Mar; 112(3):740-8. PubMed ID: 11260079
[TBL] [Abstract][Full Text] [Related]
17. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon.
Faber LM; van Luxemburg-Heijs SA; Rijnbeek M; Willemze R; Falkenburg JH
Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352
[TBL] [Abstract][Full Text] [Related]
18. Effects of interferon-alpha (IFN) on the expression of interleukin 1-beta (IL-1), interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF) in acute myeloid leukemia (AML) blasts.
Sissolak G; Hoffbrand AV; Mehta AB; Ganeshaguru K
Leukemia; 1992 Nov; 6(11):1155-60. PubMed ID: 1434798
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte/macrophage-colony-stimulating-factor plus interleukin-2 plus interferon alpha in the treatment of metastatic renal cell carcinoma: a pilot study.
Westermann J; Reich G; Kopp J; Haus U; Dörken B; Pezzutto A
Cancer Immunol Immunother; 2001 Jan; 49(11):613-20. PubMed ID: 11225992
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte-macrophage colony-stimulating factor induces the differentiation of murine erythroleukaemia cells into dendritic cells.
Cao X; Zhao Y; Yu Y; Wang Y; Zhang M; Zhang W; Wang J
Immunology; 1998 Sep; 95(1):141-7. PubMed ID: 9767469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
